- Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business.
- Acquisition is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio
- With the addition of around 100 new employees as well as state-of-the-art production and R&D facilities in Korea, Merck will expand both its regional and global capabilities
- As part of the “Level Up” growth program of Merck’s Electronics business sector, the acquisition will further drive innovation in Semiconductor Solutions, one of Merck’s “Big 3” growth engines
According to the company’s website press release on January 2, 2023, Merck, a leading science and technology company, announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business. Combining these two businesses is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio, while simultaneously building on the company’s localization efforts.
The closing of the transaction followed regulatory clearance and the fulfillment of other customary closing conditions. As a result of the acquisition, Merck will gain approximately 100 employees, as well as state-of-the-art production and R&D sites in Korea. The acquisition is part of the “Level Up” growth program of Merck’s Electronics business sector, which includes investments of significantly more than € 3 billion from 2021 to 2025 in innovation and capacities, focusing on four, mutually reinforcing key priorities: scale, technology, portfolio, as well as capabilities.
“We’re delighted to announce our recent closing of the acquisition and continue expanding our regional capabilities in Korea, as well as our overall global capacity. The acquisition of M Chemicals Inc. is another milestone in the expansion of our Electronics business and in particular Semiconductor Solutions, one of our “Big 3” growth engines, through targeted smaller to medium-sized acquisitions with high impact,” said Surésh Rajaraman, Senior Vice President and Head of Merck’s Thin Film Solutions Business Field.
For more information, please contact Chantal Gilsdorf
+49 151 1454 2860
https://www.merckgroup.com/en/news/chemical-closing.html#
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck generated sales of € 19.7 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
